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Abstract
Background: Bovine brucellosis remains one of the most prevalent zoonotic infections affecting dairy cattle in
developing countries where the applied control programs often fail. We analyzed the epidemiologic pattern of
bovine brucellosis in a dairy cattle herd that showed several cases of abortions after regular vaccination with RB51
(B. abortus vaccine). In 2013 thirty dairy cows, from a Holstein-Friesian dairy herd with a population of 600 cattle,
aborted five months post vaccination by a regular RB51 vaccine. Blood samples were drawn from milking cows and
growing heifers, as well as heifers and cows pregnant up to 6 months. These samples were collected in June 2013
(n = 257) and May 2014 (n = 263) and were tested by real time (rt)-PCR as well as serological tests, in particular Rose
Bengal Test (RBT), Enzyme-Linked Immunosorbent Assays (ELISA) and Fluorescence Polarization Assay. Tissue
specimens were also collected from an aborted fetus and cultured. Isolates were subjected to bacteriological typing
tests at the genus and species levels.
Results: Five months post vaccination with RB51 vaccine, Brucella (B.) DNA was detected in blood samples of cows
by rt-PCR. The serological tests also revealed the spread of Brucella field strains within the herd in 2013. Four
Brucella isolates were recovered from specimens collected from the aborted fetus. These isolates were typed as
follows: one B. abortus RB51 vaccine strain and three isolates of B. abortus field strain. The seropositive cows with
positive rt-PCR might indicate an infection by the Brucella field strain; while the positive rt-PCR results from
seronegative animals may either be due to circulating RB51 vaccine DNA in vaccinated animals or to circulating
field strain in infected animals before seroconversion.
Conclusion: The results herein suggest that PCR can be a good supplementary tool in an outbreak situation, if an
assay is available that can differentiate vaccine and field strains with a high analytical sensitivity. We recommend
using RBT and ELISA in parallel in outbreak situations, to identify as many infected animals as possible during the
initial screenings. This test procedure should be repeated for at least three successive negative tests, with one
month interval.
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Background
Brucellosis, caused by Brucella species, is considered
one of the most common bacterial zoonotic infections
worldwide. The infection is endemic in many geographic
areas including the Mediterranean and Middle East
regions, Indian subcontinent, Mexico and parts of
central and South America [1, 2]. The disease is a major
cause of direct economic loss and impedes trade among
countries [3]. The estimated annual economic loss due
to brucellosis was about 60 million Egyptian pounds in
1995 [4]. The diagnosis of Brucella infection is usually
based on clinical presentation, microbiological culture
and demonstration of specific antibodies [5]. Despite be-
ing the more commonly used technique for the initial
screening of the infection, serological tests have limita-
tions because not all infected animals produce detectable
levels of antibodies, and false-positive results are seen
due to cross-reactivity with antigens of other bacterial
species [6]. The sensitivity of bacteriological culture usu-
ally depends on the viability and number of Brucella in
the sample, as well as contamination of the sample with
other bacteria [7]. Conversely, culture methods are time-
consuming and the handling of microorganisms is haz-
ardous [5]. In order to overcome most of these difficul-
ties, PCR and real-time (rt)-PCR assays have been
employed for diagnosis and molecular typing of Brucella
species. Various PCR assays targeting different gene loci
have been successfully used for diagnosis of brucellosis
[8–12]. Species identification and sub-typing of Brucella
isolates are very important not only for epidemiologic
surveillance, but also for investigation of outbreaks in bru-
cellosis endemic regions [13, 14]. Multiple-Locus Variable
number tandem repeat Analysis (MLVA) is a useful tool
for identifying and genotyping of Brucella isolates and
data could be used for epidemiological trace back investi-
gations [15, 16].
Bovine brucellosis remains one of the most common
zoonoses in Egypt, and causes great constraints to the
Government in improving animal productivity. Although
nearly a century has passed since the first description of
Brucella in Egypt, it has not been possible to eradicate
this infection. The enforcement of control measures for
brucellosis in Egypt (test and slaughter, S19 vaccination)
have led to a reduction of B. abortus incidence in cattle
[17]. However, most of these endeavors are still not
conclusive [17, 18]. Despite being endemic, little is
known about the epidemiological situation of brucellosis
among Egyptian dairy herds. Indeed, Brucella infection
remains under-diagnosed and often underestimated. In
general, the control programs of Brucella infection in
animals relies mainly on vaccination with live attenuated
B. abortus strain 19. This provides good levels of protec-
tion against B. abortus in cattle and B.melitensis Rev. 1is
used in sheep and goats [19, 20]. When administered
correctly, the two vaccines can protect livestock from bru-
cellosis, but the vaccines still have a drawback as they re-
tain pathogenicity and sometimes cause abortion in
vaccinated animals [21] and debilitating illness in humans
[22–24]. In 2006, RB51, a mutant vaccine rough strain
that is devoid of the lipopolysaccharide O-side chain was
developed [25]. Cattle vaccinated with this kind of vaccine
remained negative in conventional brucellosis serological
tests [26]. This vaccine was suggested to be more appro-
priate than B. abortus S19 for the control and eradica-
tion programs that relied on serological testing and
removal of positive animals [27].
For the effective monitoring of bovine brucellosis, it
is imperative to have reliable tests to differentiate be-
tween vaccine and field strains. Thus, many molecular
approaches have been developed to detect vaccine
strains [28, 29]. Although extensive reports of animal
brucellosis in Egypt are currently available, the epidemio-
logic situation of this infection is still ambiguous and
needs further investigations. The purpose of this study
was to analyze the epidemiologic pattern of bovine
brucellosis in a well managed dairy farm in Egypt
through a two year study period.
Methods
Farm description and problem identification
In 2013, a string of abortions (n = 30) was reported in a
commercial dairy farm with a stock population of 600
Holstein-Friesian cattle. The farm’s records indicated
that the farm was free from brucellosis since 2008. All
animals tested negative using Rose Bengal Test (RBT)
and Buffered Acidified Plate Agglutination Test
(BAPAT) and the farm was considered an “ideal” dairy
farm. This means all effective health care programs were
enforced. All “good dairy farming” practices for animal
health are practiced under the following guidelines: pre-
venting the entry of disease onto the farm, having an ef-
fective herd health management program in place, and
using all chemicals and veterinary medicines as directed.
The farm is located in Gamasa City on the coast of the
Mediterranean Sea, Dakahlia Governorate, Egypt.
The main target groups of this study were milking
cows, growing heifers plus heifers and cows being
pregnant up to 6 months. The age of these animals ranged
between 6 - to -18 months for heifers, and 2- to-5 years
for pregnant and non pregnant cows. A routine investiga-
tion for Brucella infection was performed with cattle at
this farm in December 2012 using RBT and BAPAT and
all cattle tested negative. For this reason, all animals (ex-
cept those being pregnant > 3 months; n = 80) were
vaccinated with RB51 (B. abortus vaccine, Professional
Biological Company, USA) at the beginning of January
2013 according to the instructions of the manufacturer.
Thirty cows aborted in June 2013. As a result of this,
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the pregnant heifers (<6 months) and all cows (ex-
cept those pregnant in the third trimester) were
sampled for detailed serological and molecular
investigations of Brucella infection. With the excep-
tion of abortion, no other clinical signs appeared in
these animals during sampling. All animals on the
farm remained clinically healthy without any detect-
able illness. During the period of abortions, the farm
veterinarian exhibited some brucellosis related signs




The target groups of animals were sampled twice: in
June 2013 (n = 257) and May 2014 (n = 263). Each time,
ten ml of blood was collected through jugular vein
puncture into vacutainer tubes without anticoagulant for
separation of blood serum. The collected sera were sero-
logically examined by RBT, Enzyme-Linked Immuno-
sorbent Assays (ELISA) and Fluorescence Polarization
Assay (FPA) at Friedrich-Loeffler-Institute (FLI), OIE
reference laboratory in Jena. RBT was performed as
previously described in the Manual of Standards for
Diagnostic Tests and Vaccines [6] using antigen obtained
from Institute Pourquier, France. Positive and negative
control sera were the German national reference sera
standardized according to OIE. The ELISA was per-
formed and results were interpreted according to the
instructions of the manufactures using IDEXX™ Brucella
ELISA kit (Montpellier SAS, France). FPA was done and
results were interpreted according to the instructions of
the manufacturer (Diachemix, Whitefish Bay, WT,
USA). A blood sample was also drawn from the farm
veterinarian and was tested by RBT, ELISA, FPA and rt-
PCR. Cultural procedures and molecular diagnostic as-
says were also performed at FLI, Jena, Germany. An
informed consent for Brucella investigation was given by
the owners. All procedures were performed in ac-
cordance with the principles and specific guidelines
presented in the Guidelines for the Care and Use of
Agricultural Animals in Research and Teaching, 3rd ed.
(http://www.fass.org/docs/agguide3rd/Ag_Guide_3r-
d_ed.pdf ), and those of Mansoura University Animal
Care and approved by its Ethical Committee.
Tissue specimens
Abomasal contents, liver, kidney and spleen were
collected from an aborted fetus in June 2013 for isola-
tion of Brucella organism. All tissue samples were cooled
immediately after being collected, and were immediately
transported to the laboratory. The collected specimens
were cultured and subjected to the commonly used
bacteriological typing tests at the genus and species
(biovar) levels by classical microbiological methods [30].
DNA preparation
Genomic bacterial DNA was extracted and purified from
collected sera (n = 520) as well as bacterial isolates using
DNeasy Blood and Tissue Kit (QIAGEN, Germany)
according to the instructions of the manufacturer
using a QIAcube pipettor. DNA concentration was
determined photometrically using a Nano Drop ND-1000
UV-Vis spectrophotometer (Nano-Drop Technologies,
Wilmington, DE, USA).
PCR amplification
The extracted DNA was used for performing rt- PCR to
detect the genus specific Brucella cell surface salt
extractable bcsp31 kDa protein gene, B. abortus alkB
gene and B. melitensis BMEI1162 gene [31]. The primers
and TaqMan probes utilized for the assay were shown in
Table 1. The rt- PCR assay was prepared using the
TaqMan™ Environmental Master Mix (Applied Biosystems,
New Jersey USA) containing the following components per
reaction: 12.5 μl TaqMan™ Environmental Master Mix
(Applied Biosystems), 0.5 μl of each primer (0.2 μM) and
0.25 μl of each probe (0.1 μM). Two μl of bacterial DNA
was used as target and nuclease-free water sum up to a
total reaction volume of 25 μl. Negative Template Controls
(NTC) that contained 2 μl of water instead of DNA and
positive controls that contained DNA of Brucella were
included in each run to detect any amplicon contamination
or amplification failure. The rt - PCR reaction was
performed in duplicate in optical 96-well microtitre plates
(q PCR 96-well plates, Micro Amp TM, Applied Biosystem)
using a Mx3000P thermocycler system (Stratagene, La Jolla,
Canada) using the following reaction condition; initial
denaturation at 95 °C for 10 min, followed by 50 cycles of
95 °C for 25 s and 57 °C for 1 min. The samples scored
positive confirmed by visual inspection of the graphical
plots showing cycle numbers versus fluorescence values. A
sample with a fluorescence signal 30 times greater than the
mean standard deviation in all wells over cycles 2 through
10 was considered a positive result, whereas a sample
yielding a fluorescence signal less than this threshold value
was considered a negative result. Cycle threshold values
below 39 cycles were interpreted as positive.
Molecular identification of bacterial isolates
Species identification of Brucella isolates was per-
formed by using AMOS PCR [32]. The “Bruce-ladder
PCR” was applied to identify the vaccine strain [33].
MLVA was also done to genotype the obtained isolates
according to the previously described method using
the MLVA-16 genotyping protocol [34]. Repeat num-
bers were calculated based on allele sizes measured by
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capillary electrophoresis (Applied Biosystems® 3130
Genetic Analyzer) according to the previously de-
scribed procedure [35].
Results
Brucella infection was diagnosed in the farm by using
various serological and molecular techniques. The
detailed results of serology as well as molecular diagnos-
tic assays were reported in Tables 2 & 3. Briefly, one
hundred twenty three samples (47.9 %) were found to be
negative by using all serologic tests and rt-PCR; while
6.6 % (n = 17) yield positive by all serological tests in
combination with rt-PCR at genus and species levels.
ELISA, RBT and FPA also revealed the spread of
Brucella field strains within the herd in 2013; their
respective percentages were 11.3, 9.3 and 8.6 (Table 2).
However, 36.96 % of the tested samples (n = 95) were
seronegative but gave positive by rt-PCR where the only
species identified was B. abortus.
Four Brucella isolates were recovered from the
collected four specimens of the aborted fetus. These
isolates were typed as one vaccine strain (from liver
specimens) and three isolates of B. abortus field strain
(from spleen, abomasum and genital organs) by using
Bruce-ladder PCR (Table 3) while B. abortus was
confirmed by AMOS PCR. The three field strain isolates
showed the same MLVA-16 genotype. B. abortus was
also identified in the sample of the farm veterinarian on
the basis of a combination of serological tests (RBT,
ELISA and FPA) and rt-PCR assay. Cows that were
positive in at least two serological tests or one sero-
logical test plus the rt-PCR (n = 27) were removed from
the farm in July 2013 while RB51 vaccine was further
administered to all non pregnant heifers and parturient
cows (30-45 days post calving). In May 2014, two
hundred and sixty three samples gave negative results by
using rt-PCR, RBT, ELISA and FPA; while three samples
were seropositive.
Discussion
Among the bacterial zoonoses affecting dairy cattle in
developing countries, bovine brucellosis is considered
the most prevalent infection when the applied control
programs have failed. The infection poses not only a risk
to animals, but also represents a zoonosis with debili-
tating illness and severe complications in humans. In
Egyptian control programs for brucellosis, RB51 B.
abortus vaccine is believed to be cleared from the blood
stream within three days but can sporadically induce late
term abortions if administered to pregnant cows [36].
The agent can then persist in infected tissues of the cow
Table 1 Oligonucleotide primers and probes used in the real-time PCR assay for the detection of Brucella spp., B. abortus, and
B. melitensis
Target Primer
Brucella spp. 5`GCTCGGTTGCCAATATCAATGC 3` Forward Jena Bioscience GmbH, Germany
5`GGGTAAAGCGTCGCCAGAAG 3` Reverse
AAATCTTCCACCTTGCCCTTGCCATCA 6-FAM/BHQ1 Probe
B. abortus 5`GCGGCTTTTCTATCACGGTATTC 3` Forward
5`CATGCGCTATGATCTGGTTACG 3` Reverse
CGCTCATGCTCGCCAGACTTCAATG HEX/BHQ1 Probe
B. melitensis 5`AACAAGCGGCACCCCTAAAA 3` Forward
5`CATGCGCTATGATCTGGTTACG 3` Reverse
CAGGAGTGTTTCGGCTCAGAATAATCCACA CY5/BHQ2 Probe
6-FAM 6-carboxyfluorescein, HEX 6-hexachlorofluorescein, BHQ1 Black Hole Quencher 1, BHQ2 Black Hole Quencher 2
Table 2 Detailed results of different serological tests and real
time PCR for the detection of Brucella infection among cattle
population during two years study period





in 2013 (n = 257)
123 neg neg neg neg
95 neg neg neg pos pos
17 pos pos pos pos pos
6 neg pos neg pos pos
2 neg pos pos pos pos
4 neg neg sus neg na
5 pos neg neg neg na
2 pos pos pos neg na
2 neg pos sus neg na
1 neg neg pos neg na
Animals examined
in 2014 (n = 263)
1 neg neg sus neg na
2 neg pos pos neg na
1 neg pos sus neg na
259 neg neg neg neg
n number, neg negative, pos positive, susp suspicious, na not applicable
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and fetus/calf. The presence of Brucella DNA in blood
samples of these rare cases was supposed to be due to
intermittent bacteremia whereas the organism is located
intracellularly and may result in a persistent infection
for long time [37]. In the present study, an unexpected
high number of rt-PCR positive blood samples were
detected five months after routine vaccination. The
ninety five seronegative cows with positive rt-PCR
results may have had circulating rough RB51 vaccine
strain DNA in their blood as some researchers were able
to detect RB51 vaccine strain DNA for twenty five days
in the milk of vaccinated buffaloes although cultivation
was possible only for 4 days [38]. Longer circulation of
vaccine DNA in the blood stream is therefore a realistic
possibility for the origin of DNA found. The twenty five
serologically positive cows that showed B. abortus DNA
in their blood stream may have been infected by the field
strain. However, the seropositive animals with negative
rt-PCR results (n =10) might represent animals at differ-
ent stages of infection whenever the DNA is already
cleared from the blood stream. The same suggestion was
previously reported by Gwida et al. [39]
In general, the use of rt-PCR for the diagnosis of
brucellosis from blood samples of ruminants has been
discussed controversially. It has been supposed that the
sensitivity of PCR is dependent on the status of disease
i.e. the chronic infected animals are regularly misdiag-
nosed as no B. abortus DNA is present in respective
samples [12]. The presence of B. abortus DNA was,
however, demonstrated in blood samples from various
infected animal species and humans but with varying
sensitivities [9, 40, 41]. Recently, B. abortus and B.
melitensis DNA were detected in bovine milk which was
collected from apparently healthy animals by using
species-specific IS711 rt-PCR [42]. It has been shown
that rt-PCR could be an additional tool in an outbreak
situation when serological methods are still negative or
it might help to identify animals which are not detected
by conventional serological methods [40].
The coincidence of vaccination and the apparent
infection by a field strain in this herd which was sero-
logically negative two months prior to the administration
of the vaccine highlights the fact that RB51 vaccination
cannot protect a herd (or single animals) from being
infected with B. abortus in an endemic area. Vaccination
may only reduce economical loss for the farmer. The
sense of security conveyed by vaccination may even
result in loss of awareness and impaired biosecurity. It
was previously speculated that the vaccine strain can
transmit from vaccinated animals to pregnant animals
and cause abortion in very few cases [36]. Our findings
support such suspicions where vaccine and field strain
are isolated from the same fetus, suggesting that trans-
mission of RB51 vaccine strain from non pregnant
animals to unvaccinated pregnant animals has taken
place. Our screening system made sure that most of the
female animals used for reproduction on the farm were
investigated with all techniques during the investigation
period of two years. Vaccination and serological investi-
gation with subsequent removal of reactors may result
in the absence of abortions from July 2013 to May 2015.
Although, in the routine RBT and BAPAT screening at
May 2014, three cows tested positive which were later
on reactive in ELISA and FPA but negative in rt-PCR.
Simply, these animals could be undetected due to the
stage of infection or could be re-contaminated via new
introduction of a field strain. As a special problem for
eradication of brucellosis, are those female calves that
were borne to Brucella positive mothers. These calves
may harbor the agent during their childhood and first
pregnancy and seroconvert after they have calved [43–45].
In the setting of Egypt, such animals can run undetectable
for approximately 20 months. We strongly advice to
remove all seropositive animals from the herd although
the fact that few false positive reactors may be culled.
The farm veterinarian contracted the infection with B.
abortus during his daily work on the farm, when he was
not aware that the disease was introduced only recently.
This finding highlights the public health hazard of Brucella
infection and could be an alarm for the potential risks for
personnel elsewhere. We were unable to detect the source
of infection, or the way through which the agent was intro-
duced into the farm. It is an accepted fact that even very
well managed farms in endemic areas can easily become
contaminated [40]. It is obvious that prevention of damage
in endemic areas should involve the practices of good farm
management for biosecurity and biosafety. Therefore, we
highlighted some findings made during this outbreak. In
general, vaccination using a vaccine which does not inter-
fere with serology is advised. However, current vaccines can
cause abortions even if all recommendations are followed.
The animal owner has to be made aware of this drawback
Table 3 Characterisation of Brucella isolates of tissue specimens collected from an aborted fetus
origin Conventional methods Brucella-PCR Amos-PCR Ladder-PCR
Liver B. abortus Positive B. abortus B. abortus vaccine strain
Spleen B. abortus Positive B. abortus B. abortus field strain
Abomasal contents B. abortus Positive B. abortus B. abortus field strain
Genital organ B. abortus Positive B. abortus B. abortus field strain
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of vaccines, although it has to be stressed that the benefit
of vaccination outweighs its risks. Routine screening with a
sensitive and specific test (validation of test has to be done
in the region where it will be used) in short intervals has to
be applied. It is worthy to note that no further abortions
were recorded at the farm, since applying the strategy of
test and slaughter. By the end of April 2014, 120 cows were
culled from the farm, being either seropositive or having
concomitant ailments including mastitis, laminitis and
metritis. Special concern should be directed to females
of a Brucella infected mother or those females which
have unknown background, as such animals can be a
carrier of Brucella and may seroconvert after abortion
or calving only.
Conclusion
We believe that RBT and BAPAT is a very useful com-
bination of tests in Egypt, considering effectiveness and
cost. If introduced, serological screening should be con-
firmed by ELISA and all reactors should be removed
from the herd. All animals on the farm should be tested.
We also suggest that PCR can be a good supplementary
test for outbreak situations, as PCR can differentiate vac-
cine and field strains with high analytical sensitivity. We
also recommend using RBT and ELISA in parallel in an
outbreak situation to identify as many infected animals
as possible during the initial screenings, and to repeat
this test procedure for at least three successive negative
tests with one month interval.
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